Aethlon Medical, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Aethlon Medical, Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Of every $100 of net worth, $100 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than almost all Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 98% of Healthcare companies in United States.
- Shareholder Slice Ratio: Share count rose 5,364% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 94% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / -64%In 3 years sales changed by -100% while total assets changed by -64%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-20.8×Operating cash was negative last year, while some debt falls due within a year.
Lower than 55% of Healthcare companies in United States.
Cash Cushion Ratio
+56%Cash, after subtracting all debt, equals 56% of its market value (net cash).
Higher than 79% of Healthcare companies in United States.
Tangible Assets Ratio
100%Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 98% of Healthcare companies in United States.
Tangible Net Worth Ratio
100%Of every $100 of net worth, $100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than almost all Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Aethlon Medical, Inc. made a loss over the last year. Aethlon Medical, Inc. owes $0.23 for every $1 it owns. Aethlon Medical, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Mar 2026.
P/E ratio
LossAethlon Medical, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.70The share price is 1.70 times Aethlon Medical, Inc.'s book value per share, lower than 64% of Healthcare companies in United States.
Market cap
$8 MThe total market value of all of Aethlon Medical, Inc.'s shares at today's price (share price × number of shares), smaller than 89% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$5 MWhat Aethlon Medical, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
$3.05Net worth divided by the number of shares. The share price of $5.19 is 1.7 times this, which is the P/B above.
Return on equity (ROE)
-160.9%Aethlon Medical, Inc. lost 160.9% of its shareholders' money over the last year, lower than 80% of Healthcare companies in United States.
Owes vs Owns
0.23×Aethlon Medical, Inc. owes $0.23 for every $1 it owns (low), lower than 69% of Healthcare companies in United States.
Dividend yield
NoneAethlon Medical, Inc. does not currently pay a dividend.
Profit growth
LossAethlon Medical, Inc. made a loss in each of the last two years.
Interest cover
Not coveredAethlon Medical, Inc.'s operating profit did not cover its interest costs in the year to Mar 2026.
Cash vs debt
Net cashAethlon Medical, Inc. held $5 M more cash than debt (net cash) at Mar 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Aethlon Medical, Inc.: $8 M ÷ $5 M (31 Mar 2026) = 1.7.
What is Aethlon Medical, Inc.'s return on equity?
Aethlon Medical, Inc. lost 160.9% of its shareholders' money over the last year, lower than 80% of Healthcare companies in United States.
How much does Aethlon Medical, Inc. owe compared with what it owns?
Aethlon Medical, Inc. owes $0.23 for every $1 it owns (low), lower than 69% of Healthcare companies in United States.
Does Aethlon Medical, Inc. pay a dividend?
No. Aethlon Medical, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.